Abstract
Root extracts of Withania somnifera (Ashwagandha) are commonly used as a remedy for a variety of ailments and a general tonic for overall health and longevity in the Indian traditional medicine system, Ayurveda. We undertook a study to investigate the anti-proliferative and differentiation-inducing activities in the water extract of Ashwagandha leaves (ASH-WEX) by examining in glioma cells. Preliminary detection for phytochemicals was performed by thin-layer chromatography. Cytotoxicity was determined using trypan blue and MTT assays. Expression level of an hsp70 family protein (mortalin), glial cell differentiation marker [glial fibrillary acidic protein (GFAP)] and neural cell adhesion molecule (NCAM) were analyzed by immunocytochemistry and immunoblotting. Anti-migratory assay was also done using wound-scratch assay. Expression levels of mortalin, GFAP and NCAM showed changes, subsequent to the treatment with ASH-WEX. The data support the existence of anti-proliferative, differentiation-inducing and anti-migratory/anti-metastasis activities in ASH-WEX that could be used as potentially safe and complimentary therapy for glioma. Copyright © 2011 Hardeep Kataria et al.
Cite
CITATION STYLE
Wadhwa, R., Kataria, H., Shah, N., Kaul, S. C., & Kaur, G. (2011). Water extract of Ashwagandha leaves limits proliferation and migration, and induces differentiation in glioma cells. Evidence-Based Complementary and Alternative Medicine, 2011. https://doi.org/10.1093/ecam/nep188
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.